HLA SPREAD Data Visualization

Select Categories

Clear Filter

Show Entries

PMID	Allele	Disease	Population	Drug Names	SNP	Class
1571710	NA (NA)	busulfan	NA	cyclophosphamide	NA	unclassified
NA
1571710	NA (NA)	busulfan	NA	cyclophosphamide	NA	unclassified
NA
1571710	HLA MATCHED (HLA-MATCHED)	busulfan	NA	cyclophosphamide	NA	unclassified
NA
1571710	HLA MATCHED (HLA-MATCHED)	busulfan	NA	cyclophosphamide	NA	unclassified
NA
1619381	HLA IDENTICAL (HLA-IDENTICAL)	transplantation	NA	NA	NA	unclassified
recent progress in the practice of bone-marrow transplantation has led to a survival rate of approximately 80% in the best cases, but such a treatment is only amenable in young patients (less than 45-50 years) with hla-identical bone-marrow donors.
1622990	HLA (HLA)	transplantation	NA	NA	NA	unclassified
to establish the time course of post-transplantation sensitization, we have tested anti-hla antibodies in sequential sera at 3-month intervals after transplantation.
1622990	HLA (HLA)	atherosclerosis	NA	NA	NA	unclassified
relation of hla antibodies and graft atherosclerosis in human cardiac allograft recipients.
1638260	HLA-CLASS II (HLA CLASS II)	transplantation	NA	NA	NA	unclassified
in addition, we compare two hla class ii transplantation antigens by this method and contrast the results with a dynamic programming approach.
1639441	HLA-CLASS II (HLA-CLASS II)	transplantation	NA	NA	NA	unclassified
allelic polymorphism of hla-class ii antigens plays a key role in the regulation of the immune response and in transplantation immunity.
1644446	HLA-B*27	transplantation	Spanish	NA	NA	unclassified
this procedure of genotyping b27 alleles is a reliable method which can be used in transplantation and b27-associated disease studies.

HLA Web Resource for SNPs, Populations, Resources, ADRs, Diseases

Select Categories

Contact Us :